These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36436241)

  • 21. Prognostic and predictive value of the newly proposed grading system of invasive pulmonary adenocarcinoma in Chinese patients: a retrospective multicohort study.
    Hou L; Wang T; Chen D; She Y; Deng J; Yang M; Zhang Y; Zhao M; Zhong Y; Ma M; Zhao G; Chen Y; Xie D; Zhu Y; Chen Q; Wu C; Chen C;
    Mod Pathol; 2022 Jun; 35(6):749-756. PubMed ID: 35013526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system.
    Nomura K; Aokage K; Kaminuma Y; Nakai T; Wakabayashi M; Ikeno T; Koike Y; Taki T; Miyoshi T; Tane K; Samejima J; Ishii G; Tsuboi M
    Int J Clin Oncol; 2024 Mar; 29(3):248-257. PubMed ID: 38319510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic impact of the IASLC grading system of lung adenocarcinoma: a systematic review and meta-analysis.
    Hegedűs F; Zombori-Tóth N; Kiss S; Lantos T; Zombori T
    Histopathology; 2024 Jul; 85(1):51-61. PubMed ID: 38485464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.
    Warth A; Muley T; Meister M; Stenzinger A; Thomas M; Schirmacher P; Schnabel PA; Budczies J; Hoffmann H; Weichert W
    J Clin Oncol; 2012 May; 30(13):1438-46. PubMed ID: 22393100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.
    Kadota K; Villena-Vargas J; Yoshizawa A; Motoi N; Sima CS; Riely GJ; Rusch VW; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2014 Apr; 38(4):448-60. PubMed ID: 24472852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does the histologic predominance of pathological stage IA lung adenocarcinoma influence the extent of resection?
    Ito H; Nakayama H; Murakami S; Yokose T; Katayama K; Miyata Y; Okada M
    Gen Thorac Cardiovasc Surg; 2017 Sep; 65(9):512-518. PubMed ID: 28593420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society grading system has limited prognostic significance in advanced resected pulmonary adenocarcinoma.
    Westaway DD; Toon CW; Farzin M; Sioson L; Watson N; Brady PW; Marshman D; Mathur MM; Gill AJ
    Pathology; 2013 Oct; 45(6):553-8. PubMed ID: 24018816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The IASLC Proposed Grading System Accurately Predicts Prognosis and Mediastinal Nodal Metastasis in Patients With Clinical Stage I Lung Adenocarcinoma.
    Xu L; Su H; Hou L; Wang F; Xie H; She Y; Gao J; Zhao S; Dai C; Xie D; Zhu Y; Wu C; Zhao D; Chen C;
    Am J Surg Pathol; 2022 Dec; 46(12):1633-1641. PubMed ID: 36224092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Battle for Accuracy: Identifying the Most Effective Grading System for Lung Invasive Mucinous Adenocarcinoma.
    Jia J; Zhang G; Wei L; Qi L; Wang X; Li L; Zeng H; Wang J; Xue Q; Ying J; Xue L
    Ann Surg Oncol; 2024 Sep; 31(9):5717-5728. PubMed ID: 38847985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different prognostic role of EGFR mutation according to the IASLC histological grade in patients with resected early-stage lung adenocarcinoma.
    Hong TH; Hwang S; Choi YL; Lee G; Park S; Ahn MJ; Lee Y; Jeon YJ; Lee J; Shin S; Park SY; Cho JH; Choi YS; Kim J; Shim YM; Cho J; Kim HK
    Histopathology; 2023 Aug; 83(2):168-177. PubMed ID: 36849852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of the Novel International Association for the Study of Lung Cancer Grading System for Invasive Pulmonary Adenocarcinoma and Association With Common Driver Mutations.
    Deng C; Zheng Q; Zhang Y; Jin Y; Shen X; Nie X; Fu F; Ma X; Ma Z; Wen Z; Wang S; Li Y; Chen H
    J Thorac Oncol; 2021 Oct; 16(10):1684-1693. PubMed ID: 34302987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the new IASLC/ATS/ERS proposed classification of adenocarcinoma based on lepidic pattern in patients with pathological stage IA pulmonary adenocarcinoma.
    Nakagiri T; Sawabata N; Morii E; Inoue M; Shintani Y; Funaki S; Okumura M
    Gen Thorac Cardiovasc Surg; 2014 Nov; 62(11):671-7. PubMed ID: 24890089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors of recurrence for resected T1aN0M0 invasive lung adenocarcinoma: a clinicopathologic study of 177 patients.
    Yang F; Chen K; Liao Y; Li X; Sun K; Bao D; Wang J
    World J Surg Oncol; 2014 Sep; 12():285. PubMed ID: 25216551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incorporation of the lepidic component as an additional pathological T descriptor for non-small cell lung cancer: Data from 3335 cases of lung adenocarcinoma.
    Huang S; Zhao M; Li S; Chen T; Zhong Y; Deng J; Xu L; Wu J; Xie X; Wu C; Hou L; She Y; Zheng H; Chen C
    Lung Cancer; 2024 Mar; 189():107472. PubMed ID: 38320371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic disease.
    Arrieta O; Salas AA; Cardona AF; Díaz-García D; Lara-Mejía L; Escamilla I; García AP; Pérez EC; Raez LE; Rolfo C; Rosell R
    Lung Cancer; 2021 May; 155():183-190. PubMed ID: 33558063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic impact of mitosis and necrosis in non-mucinous lung adenocarcinomas and correlation with IASLC grading system.
    Serın G; Savaş P; İşgör İŞ; Özdıl A; Mizrak A; Veral A; Nart D
    Histol Histopathol; 2024 Jun; 39(6):703-714. PubMed ID: 37724635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy of
    Lococo F; Guerrera F; Rena O; Ampollini L; Vannucci J; Bertoglio P; Ventura L; Lyberis P; Marchese V; Arena V; Filosso PL; Lesca A; Casadio C; Viti A; Paci M; Puma F; Ruffini E
    Heart Lung Circ; 2022 May; 31(5):726-732. PubMed ID: 34753661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma.
    Hung JJ; Jeng WJ; Chou TY; Hsu WH; Wu KJ; Huang BS; Wu YC
    Ann Surg; 2013 Dec; 258(6):1079-86. PubMed ID: 23532112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 18F-fluorodeoxyglucose positron emission tomographic scan in solid-type p-stage-I pulmonary adenocarcinomas: what can produce false-negative results?
    Lococo F; Galeone C; Formisano D; Bellafiore S; Filice A; Annunziata T; Cesario A; Rapicetta C; Fioroni F; Ricchetti T; Paci M
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):667-673. PubMed ID: 28043987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Radiopathological Grading System to Tailor Recurrence Risk for Pathologic Stage IA Lung Adenocarcinoma.
    Qiu ZB; Wang MM; Yan JH; Zhang C; Wu YL; Zhang S; Zhong WZ;
    Semin Thorac Cardiovasc Surg; 2023 Autumn; 35(3):594-602. PubMed ID: 35709883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.